ASPEN PHARMACARE HOLDINGS LIMITED - Results for the half-year ended 31 December 2015 and interim results presentation

Results for the half-year ended 31 December 2015 and interim results presentation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Company”)



ASPEN’S RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2015 AND INTERIM RESULTS PRESENTATION

Shareholders are advised that Aspen intends releasing its results for the year ended 31 December 2015 on
Thursday, 3 March 2016 on SENS. This announcement will be followed by a presentation to members of
the investment community on Friday, 4 March 2016 in Cape Town.

All interested stakeholders are invited to dial into the presentation scheduled for 08h30 (CAT) on
4 March 2016. Participation will be live but on a listen-in basis only and those interested are requested to
dial the numbers detailed below by no later than 08h15 (CAT) in order to register for the call.

Conference call dial-in details – please dial one of the following numbers:

+27 11 353 3600
+27 10 201 6800

The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com)
in the Investor Information section shortly before the commencement of the presentation on
4 March 2016.

A playback of this presentation will be made available until 30 April 2016 – this playback can be accessed by
dialling one of the following numbers:

South Africa & Other:   +27 11 305 2030
UK:                     0 808 234 6771
USA & Canada:           1 855 481 5363
Australia:              1 800 091 250

Replay code:            44316#



Durban
1 March 2016

Sponsor:
Investec Bank Limited

Date: 01/03/2016 12:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.